Abstract
DW/J dwarf mice have a defect in their anterior pituitary and are deficient in growth hormone (GH) and prolactin (PRL). These mice have been demonstrated previously to have a deficiency in CD4/CD8 double- positive thymocytes, which could be corrected by treatment of these mice with recombinant human GH. Since PRL has been implicated in T cell function and human GH can interact with the PRL receptor, DW/J dwarf mice were treated with either ovine GH (ovGH) (20 micrograms/d) or ovine PRL (ovPRL) (20 micrograms/d). The ovine hormones can only bind their own specific receptors in the mouse. After several weeks of treatment, it was found that these two hormones produced markedly contrasting effects on T cells. Phenotypic analysis of the lymphoid organs was performed by flow cytometry and the functional capability of the peripheral T cells was assessed by immunizing the mice and determining the extent of antigen-specific proliferation of T cells obtained from the draining lymph nodes or by determining splenic mitogen responses. The results indicated that ovGH administration to dwarf mice resulted in significant increases in thymic cellularity yet had little effect on peripheral T cell responses. In contrast, the administration of ovPRL resulted in a further decrease in thymic cellularity when compared with untreated dwarf mice. No thymic effects of either ovGH or ovPRL administration were detected on the normal +/? counterparts. However, ovPRL administration resulted in a significant increase in the number and function of antigen-specific peripheral T cells in both immunized dwarf and +/? mice. The adjuvant effects of PRL occurred even though the mice also received complete Freund's adjuvant. These results suggest that neuroendocrine hormones may act in concert in T cell development. GH appears to promote thymocyte proliferation, while PRL appears to decrease thymus size and yet augment the number and function of antigen-specific T cells in the periphery.
Full Text
The Full Text of this article is available as a PDF (562.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cross R. J., Bryson J. S., Roszman T. L. Immunologic disparity in the hypopituitary dwarf mouse. J Immunol. 1992 Mar 1;148(5):1347–1352. [PubMed] [Google Scholar]
- Dardenne M., Kelly P. A., Bach J. F., Savino W. Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9700–9704. doi: 10.1073/pnas.88.21.9700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duquesnoy R. J. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. J Immunol. 1972 Jun;108(6):1578–1590. [PubMed] [Google Scholar]
- Fabris N., Pierpaoli W., Sorkin E. Hormones and the immunological capacity. 3. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol. 1971 Aug;9(2):209–225. [PMC free article] [PubMed] [Google Scholar]
- Frantz A. G. Prolactin. N Engl J Med. 1978 Jan 26;298(4):201–207. doi: 10.1056/NEJM197801262980408. [DOI] [PubMed] [Google Scholar]
- Kelley K. W., Brief S., Westly H. J., Novakofski J., Bechtel P. J., Simon J., Walker E. B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5663–5667. doi: 10.1073/pnas.83.15.5663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McMurray R., Keisler D., Kanuckel K., Izui S., Walker S. E. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol. 1991 Dec 1;147(11):3780–3787. [PubMed] [Google Scholar]
- Murphy W. J., Durum S. K., Anver M. R., Longo D. L. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol. 1992 Jun 15;148(12):3799–3805. [PubMed] [Google Scholar]
- Murphy W. J., Durum S. K., Longo D. L. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J Immunol. 1992 Dec 15;149(12):3851–3857. [PubMed] [Google Scholar]
- Murphy W. J., Tsarfaty G., Longo D. L. Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood. 1992 Sep 15;80(6):1443–1447. [PubMed] [Google Scholar]
- Rui H., Djeu J. Y., Evans G. A., Kelly P. A., Farrar W. L. Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem. 1992 Nov 25;267(33):24076–24081. [PubMed] [Google Scholar]
- Sabharwal P., Glaser R., Lafuse W., Varma S., Liu Q., Arkins S., Kooijman R., Kutz L., Kelley K. W., Malarkey W. B. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7713–7716. doi: 10.1073/pnas.89.16.7713. [DOI] [PMC free article] [PubMed] [Google Scholar]